Renchen Bio

Renchen Bio

壬辰生物

Renchen Bio

Biotech/Healthcare

Founded in 2020, Renchen Biotech discovered and validated novel biomarkers associated with the screening and diagnosis of preterm birth and preeclampsia. It also achieved highly efficient and precise capture and isolation of human trophoblast stem cells, enabling reliable, noninvasive early…

Latest round: Angel (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-09-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.